Literature DB >> 26962547

Feasibility of Transient Elastography with M and XL probes in real life.

Ioan Sporea1, Roxana Șirli2, Ruxandra Mare1, Alina Popescu1, Siegfried Cristian Ivașcu1.   

Abstract

AIM: Reliable liver stiffness measurements (RLSM) using Transient Elastography (TE) with the standard M probe are difficult to obtain in overweight (BMI≥25kg/m2) and obese (BMI>30kg/m2) patients. The aim of our paper was to assess the feasibility of TE in daily practice using both M and XL probes. MATERIAL AND
METHOD: We studied retrospectively 3235 patients with chronic liver disease assessed by TE first by the M probe (standard probe – transducer frequency 3.5 MHz), and if the measurements were unreliable, with the XL probe (transducer frequency 2.5 MHz). Reliable measurements were defined as the median of 10 valid measurements with a success rate ≥ 60% and an interquartile range < 30%. Results of liver elasticity were expressed in kilo Pascals (kPa).
RESULTS: RLSM by M probe were obtained in 62.2% (2015/3235) patients, and by XL probe in 1011/1220 (80%) of patients with unreliable measurements by M probe; thus we obtained RLSM in 93.5% of 3235 cases. In overweight patients we obtained RLSM in 89.9% (1039/1156) cases: in 63.1% (729) by M probe and in 26.8% (310) by XL probe. In obese patients we obtained RLSM in 83.8% (746/890): in 18.4% (164) by M probe and in 65.4% (582) by XL probe. Thus, by using both probes, RLSM were obtained in 1785 (87.2%) of overweight and obese patients.
CONCLUSION: The feasibility of the M probe was 62.2% in our Department. Reliable measurements using M or XL probe allowed the evaluation of liver stiffness in 93.5% of cases. By using both M and XL probes, reliable LSM by TE can be obtained in the majority of obese and overweight patients (87.2%).

Entities:  

Mesh:

Year:  2016        PMID: 26962547     DOI: 10.11152/mu.2013.2066.181.xsi

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  5 in total

Review 1.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

2.  Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.

Authors:  Mazen Noureddin; Micaela M Wong; Tsuyoshi Todo; Shelly C Lu; Arun J Sanyal; Edward A Mena
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

Review 3.  Role of Ultrasound Methods for the Assessment of NAFLD.

Authors:  Golo Petzold
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

4.  Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.

Authors:  Ioan Sporea; Ruxandra Mare; Alina Popescu; Silviu Nistorescu; Victor Baldea; Roxana Sirli; Adina Braha; Alexandra Sima; Romulus Timar; Raluca Lupusoru
Journal:  J Clin Med       Date:  2020-04-06       Impact factor: 4.241

Review 5.  Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.

Authors:  Rafael Paternostro; Thomas Reiberger; Theresa Bucsics
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.